Tapewire

NYSE · USD

MRK

Merck & Co., Inc.

Export transactions ↓
Tapewire entity
2807
SEC CIK
0000310158
Parsed reports
1,951

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 2026016
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026017
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2016 Filed Feb 24, 2016 17:38 UTC GrantCommon Stock 16,326 $50.77 $828,871.02
Disclosure

SEC source: 0001225208-16-027762 · doc4.xml · nonDerivative · entry 1

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,066.183

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2016 Filed Feb 24, 2016 17:38 UTC
Holston Michael JEVP, General Counsel
GrantCommon Stock 11,443 $50.77 $580,961.11
Disclosure

SEC source: 0001225208-16-027763 · doc4.xml · nonDerivative · entry 1

Holston Michael J · CIK 0001390613 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,081.319

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2016 Filed Feb 24, 2016 17:38 UTC
Rosenblatt MichaelExec V-P & Chief Med Officer
GrantCommon Stock 7,738 $50.77 $392,858.26
Disclosure

SEC source: 0001225208-16-027764 · doc4.xml · nonDerivative · entry 1

Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,133.076

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2016 Filed Feb 24, 2016 17:38 UTC
Schechter Adam HEVP & Pres-Global Human Health
GrantCommon Stock 37,223 $50.77 $1,889,811.71
Disclosure

SEC source: 0001225208-16-027765 · doc4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,223

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.

Read SEC document
February 22, 2016 Filed Feb 24, 2016 17:38 UTC
PERLMUTTER ROGER MExe V-P & Pres, MRL
GrantCommon Stock 25,227 $50.77 $1,280,774.79
Disclosure

SEC source: 0001225208-16-027766 · doc4.xml · nonDerivative · entry 1

PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,227

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.

Read SEC document
December 31, 2015 Filed Jan 4, 2016 18:58 UTC GrantPhantom Stock · Derivative 544.3014 $52.82 $28,750.00
Disclosure

SEC source: 0001225208-16-023076 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,219.9574

Underlying: Common Stock · 544.3014 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2015 Filed Jan 4, 2016 18:59 UTC GrantPhantom Stock · Derivative 686.2931 $52.82 $36,250.00
Disclosure

SEC source: 0001225208-16-023077 · doc4.xml · derivative · entry 2

HARRISON WILLIAM B JR · CIK 0001179576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,166.2473

Underlying: Common Stock · 686.2931 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2015 Filed Jan 4, 2016 18:59 UTC GrantPhantom Stock · Derivative 473.3056 $52.82 $25,000.00
Disclosure

SEC source: 0001225208-16-023078 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,940.864

Underlying: Common Stock · 473.3056 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2015 Filed Jan 4, 2016 19:00 UTC GrantPhantom Stock · Derivative 520.6361 $52.82 $27,500.00
Disclosure

SEC source: 0001225208-16-023079 · doc4.xml · derivative · entry 3

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,169.967

Underlying: Common Stock · 520.6361 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2015 Filed Jan 4, 2016 19:00 UTC GrantPhantom Stock · Derivative 473.3056 $52.82 $25,000.00
Disclosure

SEC source: 0001225208-16-023080 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,196.037

Underlying: Common Stock · 473.3056 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
November 04, 2015 Filed Nov 4, 2015 21:37 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $34.44 $0.00
Disclosure

SEC source: 0001225208-15-020376 · doc4.xml · derivative · entry 4

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2016-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.

Read SEC document
November 04, 2015 Filed Nov 4, 2015 21:37 UTC SaleCommon Stock 5,000 $55.53 $277,669.00
Disclosure

SEC source: 0001225208-15-020376 · doc4.xml · nonDerivative · entry 2

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.5300 to $55.5378, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

Read SEC document
November 04, 2015 Filed Nov 4, 2015 21:37 UTC Exercise / conversionCommon Stock 5,000 $34.44 $172,200.00
Disclosure

SEC source: 0001225208-15-020376 · doc4.xml · nonDerivative · entry 1

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2015 Filed Nov 4, 2015 21:37 UTC
FRAZIER KENNETH CDirector · Chairman, President & CEO
GiftCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-15-020377 · doc4.xml · nonDerivative · entry 1

FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,236.063

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 29, 2015 Filed Oct 29, 2015 20:23 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionStock Option (right to buy) · Derivative 37,313 $0.00 Strike: $36.56 $0.00
Disclosure

SEC source: 0001225208-15-020026 · doc4.xml · derivative · entry 3

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,313 shares

Expires 2021-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.

Read SEC document
October 29, 2015 Filed Oct 29, 2015 20:23 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
SaleCommon Stock 37,313 $55.08 $2,055,334.37
Disclosure

SEC source: 0001225208-15-020026 · doc4.xml · nonDerivative · entry 2

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,694.635

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.9100 to $55.1900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 29, 2015 Filed Oct 29, 2015 20:23 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionCommon Stock 37,313 $36.56 $1,364,163.28
Disclosure

SEC source: 0001225208-15-020026 · doc4.xml · nonDerivative · entry 1

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,007.635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2015 Filed Oct 30, 2015 20:58 UTC
FRAZIER KENNETH CDirector · Chairman, President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,666 $0.00 Strike: $35.09 $0.00
Disclosure

SEC source: 0001225208-15-020111 · doc4.xml · derivative · entry 4

FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,666 shares

Expires 2016-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009.

Read SEC document
October 29, 2015 Filed Oct 30, 2015 20:58 UTC
FRAZIER KENNETH CDirector · Chairman, President & CEO
SaleCommon Stock 18,666 $54.69 $1,020,757.68
Disclosure

SEC source: 0001225208-15-020111 · doc4.xml · nonDerivative · entry 2

FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,236.063

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.6200 to $54.8000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 29, 2015 Filed Oct 30, 2015 20:58 UTC
FRAZIER KENNETH CDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 18,666 $35.09 $654,989.94
Disclosure

SEC source: 0001225208-15-020111 · doc4.xml · nonDerivative · entry 1

FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 456,902.063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 28, 2015 Filed Oct 28, 2015 18:44 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $34.44 $0.00
Disclosure

SEC source: 0001225208-15-019947 · doc4.xml · derivative · entry 3

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2016-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.

Read SEC document
October 28, 2015 Filed Oct 28, 2015 18:44 UTC SaleCommon Stock 5,000 $54.85 $274,237.00
Disclosure

SEC source: 0001225208-15-019947 · doc4.xml · nonDerivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.8000 to $54.8800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

Read SEC document
October 28, 2015 Filed Oct 28, 2015 18:44 UTC Exercise / conversionCommon Stock 5,000 $34.44 $172,200.00
Disclosure

SEC source: 0001225208-15-019947 · doc4.xml · nonDerivative · entry 1

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 18:34 UTC GrantPhantom Stock · Derivative 506.1753 $49.39 $25,000.00
Disclosure

SEC source: 0001225208-15-018841 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,160.5244

Underlying: Common Stock · 506.1753 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 18:34 UTC GrantPhantom Stock · Derivative 556.7929 $49.39 $27,500.00
Disclosure

SEC source: 0001225208-15-018842 · doc4.xml · derivative · entry 3

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,096.9639

Underlying: Common Stock · 556.7929 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 18:34 UTC GrantPhantom Stock · Derivative 506.1753 $49.39 $25,000.00
Disclosure

SEC source: 0001225208-15-018843 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,951.3594

Underlying: Common Stock · 506.1753 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 18:34 UTC GrantPhantom Stock · Derivative 733.9542 $49.39 $36,250.00
Disclosure

SEC source: 0001225208-15-018844 · doc4.xml · derivative · entry 2

HARRISON WILLIAM B JR · CIK 0001179576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,825.5632

Underlying: Common Stock · 733.9542 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 18:34 UTC GrantPhantom Stock · Derivative 582.1016 $49.39 $28,750.00
Disclosure

SEC source: 0001225208-15-018845 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,315.8874

Underlying: Common Stock · 582.1016 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 01, 2015 Filed Sep 2, 2015 19:41 UTC GrantPhantom Stock · Derivative 1,665.7148 $52.53 $87,500.00
Disclosure

SEC source: 0001225208-15-017863 · doc4.xml · derivative · entry 2

Craig Pamela J. · CIK 0001232910 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,665.7148

Underlying: Common Stock · 1,665.7148 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
September 01, 2015 Filed Sep 2, 2015 19:41 UTC
Rothman PaulDirector
GrantPhantom Stock · Derivative 1,665.7148 $52.53 $87,500.00
Disclosure

SEC source: 0001225208-15-017864 · doc4.xml · derivative · entry 2

Rothman Paul · CIK 0001601332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,665.7148

Underlying: Common Stock · 1,665.7148 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
August 01, 2015 Filed Aug 4, 2015 18:41 UTC
Holston Michael JEVP, General Counsel
Exercise / conversionRestricted Stock Unit · Derivative 22,584 $58.96 $1,331,552.64
Disclosure

SEC source: 0001225208-15-016367 · doc4.xml · derivative · entry 3

Holston Michael J · CIK 0001390613 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,584 shares

Expires 2015-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
August 01, 2015 Filed Aug 4, 2015 18:41 UTC
Holston Michael JEVP, General Counsel
Tax withholdingCommon Stock 10,168 $58.96 $599,505.28
Disclosure

SEC source: 0001225208-15-016367 · doc4.xml · nonDerivative · entry 2

Holston Michael J · CIK 0001390613 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,416

Read SEC document
August 01, 2015 Filed Aug 4, 2015 18:41 UTC
Holston Michael JEVP, General Counsel
Exercise / conversionCommon Stock 22,584 $0.00 $0.00
Disclosure

SEC source: 0001225208-15-016367 · doc4.xml · nonDerivative · entry 1

Holston Michael J · CIK 0001390613 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,275 $0.00 Strike: $45.85 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 17

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,275 shares

Expires 2016-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option became exercisable in equal installments on 11/1/2007, 11/1/2008 and 11/1/2009.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,602 $0.00 Strike: $33.49 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 16

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,602 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 8,085 $0.00 Strike: $36.56 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 15

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,085 shares

Expires 2021-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option became exercisable in equal installments on 5/4/2012, 5/4/2013, 5/4/2014.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 14,260 $0.00 Strike: $39.29 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 14

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,260 shares

Expires 2022-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,120 $0.00 Strike: $44.19 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 13

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,120 shares

Expires 2017-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionStock Option (right to buy) · Derivative 5,200 $0.00 Strike: $44.30 $0.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · derivative · entry 12

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,200 shares

Expires 2018-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
SaleCommon Stock 30,065 $59.09 $1,776,652.09
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 10

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,163.12

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.0600 to $59.1250, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2 · balance_after: Since the date of the reporting person's last ownership report, Mr. Golestani transferred 953 shares of common stock of Merck & Co., Inc. to his former spouse pursuant to a domestic relations order. Holding also include shares acquired in dividend reinvestment transactions.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
SaleCommon Stock 912 $58.98 $53,787.02
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 9

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,228.12

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
SaleCommon Stock 838 $58.98 $49,421.80
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 8

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,140.12

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
SaleCommon Stock 16 $58.98 $943.68
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 7

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,978.12

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 2,275 $45.85 $104,308.75
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 6

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,994.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 2,602 $33.49 $87,140.98
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 5

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,719.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 3,120 $44.19 $137,872.80
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 4

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,117.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 5,200 $44.30 $230,360.00
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 3

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,997.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 8,085 $36.56 $295,587.60
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 2

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,797.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2015 Filed Aug 4, 2015 18:41 UTC
Golestani ClarkEVP & Chief Info Officer
Exercise / conversionCommon Stock 14,260 $39.29 $560,275.40
Disclosure

SEC source: 0001225208-15-016368 · doc4.xml · nonDerivative · entry 1

Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,712.12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2015 Filed Jul 1, 2015 20:34 UTC GrantPhantom Stock · Derivative 505.0061 $56.93 $28,750.00
Disclosure

SEC source: 0001225208-15-014676 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,420.5858

Underlying: Common Stock · 505.0061 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.